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Abstract
Background: Hydrogen peroxide (H2O2) produced by vaginal lactobacilli is generally believed to protect against
bacteria associated with bacterial vaginosis (BV), and strains of lactobacilli that can produce H2O2 are being
developed as vaginal probiotics. However, evidence that led to this belief was based in part on non-physiological
conditions, antioxidant-free aerobic conditions selected to maximize both production and microbicidal activity of
H2O2. Here we used conditions more like those in vivo to compare the effects of physiologically plausible
concentrations of H2O2 and lactic acid on a broad range of BV-associated bacteria and vaginal lactobacilli.
Methods: Anaerobic cultures of seventeen species of BV-associated bacteria and four species of vaginal lactobacilli
were exposed to H2O2, lactic acid, or acetic acid at pH 7.0 and pH 4.5. After two hours, the remaining viable
bacteria were enumerated by growth on agar media plates. The effect of vaginal fluid (VF) on the microbicidal
activities of H2O2 and lactic acid was also measured.
Results: Physiological concentrations of H2O2 (< 100 μM) failed to inactivate any of the BV-associated bacteria
tested, even in the presence of human myeloperoxidase (MPO) that increases the microbicidal activity of H2O2.A t
10 mM, H2O2 inactivated all four species of vaginal lactobacilli but only one of seventeen species of BV-associated
bacteria. Moreover, the addition of just 1% vaginal fluid (VF) blocked the microbicidal activity of 1 M H2O2.I n
contrast, lactic acid at physiological concentrations (55-111 mM) and pH (4.5) inactivated all the BV-associated
bacteria tested, and had no detectable effect on the vaginal lactobacilli. Also, the addition of 10% VF did not block
the microbicidal activity of lactic acid.
Conclusions: Under optimal, anaerobic growth conditions, physiological concentrations of lactic acid inactivated
BV-associated bacteria without affecting vaginal lactobacilli, whereas physiological concentrations of H2O2
produced no detectable inactivation of either BV-associated bacteria or vaginal lactobacilli. Moreover, at very high
concentrations, H2O2 was more toxic to vaginal lactobacilli than to BV-associated bacteria. On the basis of these in
vitro observations, we conclude that lactic acid, not H2O2, is likely to suppress BV-associated bacteria in vivo.
Background
Bacterial vaginosis (BV) is a common, frequently recur-
rent condition in which a relatively sparse, lactobacilli-
dominated vaginal microbial community is replaced by a
dense mixture of Gram-variable and Gram-negative bac-
teria. Since hydrogen peroxide (H2O2) is a broad-spec-
trum microbicidal disinfectant, the ability of some
strains of lactobacilli to produce H2O2 suggested that
these strains might help prevent BV. Women with
H2O2-producing lactobacilli are less likely to have BV
than are women without H2O2-producing lactobacilli
[1-3]. Additionally, H2O2-producing lactobacilli were
shown to inactivate several species of BV-associated bac-
teria under aerobic in vitro conditions and in the
absence of the anti-oxidants present in physiological
fluids [4,5]. Lactobacilli strains that produce H2O2 are
now being selected for developing vaginal probiotics
[6-8].
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that under the hypoxic conditions that generally prevail
in the vagina, H2O2 production by vaginal lactobacilli is
undetectable (detection threshold 10 nM). Even with
extended aerobic exposures in vitro, the mean H2O2
concentration achieved by lactobacilli in vaginal fluid
(VF) was only 23 μM±5μM, approximately 100-fold
lower than the concentration of H2O2 achieved by lacto-
bacilli under aerobic in vitro conditions in the absence
of anti-oxidants. Furthermore, VF has sufficient anti-oxi-
dant activity to block the microbicidal activity of H2O2
even when H2O2 is supplied at concentrations much
higher than lactobacilli are capable of producing. We
believe these findings make protection by H2O2 implau-
sible in vivo.
Vaginal lactobacilli produce several target-specific
antimicrobial factors, including bacteriocins [10,11], bac-
teriocins-like substances [12], and selective ligands [13].
However, given the broad spectrum of BV-associated
bacteria and the diverse reproductive tract infections
that occur more frequently in women with BV, we
chose to compare the microbicidal activities of the most
robust broad-spectrum antimicrobials that lactobacilli
are known to produce: H2O2 and lactic acid. Hydrogen
peroxide causes oxidative stress in bacterial cells [14], at
least partially by oxidizing sulphydrals, and by oxidizing
free iron to produce hydroxyl radicals that react with
nucleic acids [15]. Lactic acid, under acidic conditions,
can permeate cell membranes, acidify the cytosol
[16,17], and induce osmotic stress [18]. Lactic acid has
also been shown to have broad spectrum activity against
Gram-negative bacteria, probably by weakening the cell
wall [19]. To clarify whether cytosolic acidification is the
primary anti-microbial action of lactic acid, we also
observed the effects of acetic acid, which is elevated dur-
ing episodes of BV [20,21], and which, by being smaller
and more lipid soluble, can acidify cytosol more rapidly
than lactic acid [22].
The aim of this study, therefore, was to compare the
antimicrobial actions of H2O2, lactic acid, and acetic
acid on BV-associated bacteria and on vaginal lactoba-
cilli under anaerobic growing conditions that approxi-
mate the hypoxic environment of the vagina [23]. We
also examined the effects of VF, which consists of endo-
cervical mucus that has entered the vagina and mixed
with shed cells and transudated fluid from the vaginal
epithelium. VF is acidified with lactic acid to ≤ pH 4.5 if
the vaginal microbial community is dominated by lacto-
bacilli [24]. We selected seventeen different species of
bacteria that have been associated with BV by either
bacteriological or molecular methods. We also studied
four of the most common species of vaginal lactobacilli,
including the recently identified Lactobacillus iners.W e
tested microbicidal activity at pH 4.5 (the highest non-
menstrual vaginal pH expected in the absence of BV)
and pH 7.0 (the approximate pH of the vagina during
menses, and briefly following exposure to semen.
Methods
All materials and reagents were supplied by Sigma-
Aldrich Inc., (St. Louis MO), unless otherwise specified;
all microorganisms were supplied by the American Type
Culture Collection (Manassas VA).
Lactobacilli
Lactobacillus crispatus ATCC 33820 was grown in
ATCC medium 1490 (Modified chopped meat medium),
L. jensenii ATCC 25258 and L. gasseri ATCC were
grown in ATCC medium 416 (Lactobacilli MRS broth),
L. iners ATCC 55195 was grown in ATCC medium
1685 (NYC III medium). Each species was grown anae-
robically without agitation at 37°C for 24 hours before
use in an experiment.
Bacteria associated with bacterial vaginosis
Gardnerella vaginalis ATCC 14018 was grown in ATCC
medium 1685 (NYC III medium). Prevotella bivia
ATCC 29303, Prevotella corporis ATCC 33547, Anaero-
coccus prevotii ATCC 14952, Fusobacterium nucleatum
ATCC 25586 and Porphyromonas levii ATCC 29147
were all grown in ATCC medium 1490 (Modified
chopped meat medium); Bacteroides ureolyticus ATCC
33387 was grown in ATCC medium 1490 with formate
and fumarate. Peptostreptococcus anaerobius ATCC
27337, Anaerococcus tetradius ATCC 35098, Atopobium
vaginae ATCC BAA-55, Megasphaera elsdenii ATCC
25940, and Propionibacterium acnes ATCC 6919 were
all grown in ATCC medium 1053 (Reinforced Clostri-
dial medium) supplemented with 5% defibrinated rabbit
blood (Colorado Serum Company, Denver CO). Urea-
plasma urealyticum A T C C2 7 6 1 8w a sg r o w ni nA T C C
medium 1331 (Urea broth); Mobiluncus curtisii ATCC
35241 and Mobiluncus mulieris ATCC 35239 were
grown in BBL™ Schaedler medium (Becton, Dickinson
and Company, Sparks MD). Mycoplasma hominis
ATCC 23114 was grown in ATCC medium 243 (Myco-
plasma medium). Micromonas micros ATCC 33270 was
grown in ATCC medium 1102 (Chopped meat medium)
supplemented with 0.1% each of cellobiose, maltose,
starch, and Tween 80. Each species was grown anaerobi-
cally in a 50 mL volume of its recommended growth
medium without agitation at 37°C for 24 or 48 hours
before use in an experiment, yielding bacterial concen-
trations between approximately 10
6 and 10
9 colony-
forming units (cfu) per mL (48 hour incubations were
used for bacteria that failed to produce consistently =
10
6 cfu/mL after 24 hour incubations). The relatively
high concentrations of bacteria used were chosen both
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large numbers of bacteria permit a more meaningful
quantification of observed inactivation), and to reflect
the high density of bacteria seen in vivo [25].
Microbicidal activity
Experimental media for each organism were prepared by
adding H2O2, lactic acid, or acetic acid to the appropri-
ate growth medium for that organism; they were not
added to control media. For experiments using H2O2,
both experimental and control media contained 50 mU/
mL human myeloperoxidase (MPO). All growth medium
formulations contained at least ten-times more than the
1 mM concentration of chloride ions required for full
activity of a myeloperoxidase-halide-H2O2 microbicidal
system [26]. Aliquots of each experimental and control
medium were titrated with sodium hydroxide or hydro-
chloric acid as necessary to obtain a pH of either 4.5 or
7.0 (with allowance made for the change in pH that
would occur when an aliquot of bacterial culture was
added, as described below).
Bacterial cultures were gently agitated immediately
before use. A 100 μL aliquot of culture was added to 9.9
mL of each control or experimental medium; media and
bacteria were then incubated anaerobically at 37°C. Two
replicate samples were removed from control and
experimental conditions after ten minutes, thirty min-
utes, one hour, and two hours exposure. Each sample
was then serially diluted with the appropriate growth
medium containing 200 mM HEPES (pH 6.8-7.2
depending on growth medium) and track-plated [27]
onto the appropriate growth medium containing 1.5%
(w/v) ultrapure agar (USB Corporation, Cleveland OH).
The pH of each experimental or control medium was
re-measured after the experiment to confirm it had
remained within 0.1 pH units of the starting pH. Agar
plates were incubated anaerobically at 37°C for 24 or 48
hours, until colonies could be easily distinguished and
counted. Colonies on some plates were recounted after
a further 48 hours incubation to allow for extended lag-
phases in treated cells; however, no further changes in
colony-counts were observed. Each experiment was
independently repeated at least four times.
Bacterially-depleted vaginal fluid
Participants
The study was carried out at the Johns Hopkins Univer-
sity Homewood campus. Each participant gave written
informed consent under a protocol approved by the
Homewood Institutional Review Board on the Use of
Human Subjects at Johns Hopkins University. Partici-
pants were required to be between 18 and 45 years old,
in good general health, at least three days past the most
recent menstruation or unprotected penile-vaginal
intercourse, at least three weeks past the most recent
use of vaginal or systemic antimicrobials, and free from
vaginal symptoms (discharge, odor, itching, or pain).
Results from twenty-two samples donated by eight parti-
cipants are reported here; the group comprised roughly
equal numbers of non-Hispanic whites, blacks, and
Asians, aged between 21 and 44 years old (mean age 27
± 4 years).
Collection of vaginal fluid samples
For these experiments, undiluted non-menstrual VF was
collected at the laboratory using the non-absorbent dis-
posable Instead
® Softcup™ menstrual device (Evofem
Inc., San Diego CA) [28]. The Softcup was vaginally
inserted, removed, and placed in a conical centrifuge
tube. The collected VF was removed from the Softcup
by centrifugation for one minute at 500 g;t h eS o f t c u p
was then discarded.
A sterile cotton swab was dipped into the collected
fluid, rolled out onto a glass microscope slide, and air-
dried for later Gram-staining and Nugent-scoring. A
total of eight participants donated VF; all samples had
Nugent score ≤ 3 and no evidence of leukorrhea (the
mean PMNL/hpf of the samples was 2.3). As reported
earlier, VF samples as obtained contain ~ 1% lactic acid
and ~ 20 μMH 2O2 [9,29].
To avoid conflating endogenous vaginal bacteria with
the cultured bacteria used in these experiments, bacte-
rially-depleted VF was prepared: each collected sample
was diluted with a half-volume of sterile saline (0.9%
[w/v] sodium chloride), mixed thoroughly, centrifuged
at 1000 g for three minutes, and the supernatant was
drawn off for immediate use in an experiment. Pilot
experiments showed that this centrifugation reduced
bacterial concentrations in the diluted VF by a factor of
approximately 10
6, from a pre-centrifugation mean of
5.6 × 10
7 cfu/mL to a post centrifugation mean of 4.0 ×
10
1 cfu/mL (data not shown). Rather than pooling VF
samples for use in experiments, individual samples from
at least four different participants were used in conjunc-
tion with each treatment (H2O2 or lactic acid) to assess
the reproducibility of results across different VF
samples.
The effect of VF on the microbicidal activities of H2O2
and lactic acid against seven prevalent species of BV-
associated bacteria (G. vaginalis, A. vaginae, P. bivia, P.
anaerobius, M. curtisii, M. mulieris,a n dM. hominis)
and four species of vaginal lactobacilli was measured.
Each organism was exposed to growth medium contain-
ing an inactivating concentration of H2O2 (3.4% w/v [1
M] with 50 mU/mL MPO at pH 7) or lactic acid (1% w/
v [111 mM] at pH 4.5), with or without the addition of
bacterially depleted VF to a final VF concentration of
1% or 10% (v/v). In all cases, the bacterially depleted VF
was added to the experimental media and mixed for five
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experimental media was also checked before the addi-
tion of bacteria, and if necessary readjusted to 4.5 or
7.0. Samples were removed from control and experi-
mental conditions after ten minutes, thirty minutes, one
hour, and two hours, serially diluted, plated and enum-
erated as described above.
Statistical analysis
Results are reported as means of at least six indepen-
dently repeated experiments (two replicates performed
within each experiment). The difference between three
or more means was tested using an ANOVA one-way
analysis of variance; difference between two means was
tested using a two-tailed Student’s t test (comparisons
are paired unless otherwise indicated in the results); p
values ≤ 0.05 were considered to be statistically signifi-
cant. Statistical analysis was performed using PHStat2
version 3.0 (Microsoft Excel add-on). Due to the large
amount of data presented in the graphs, standard devia-
tions have been omitted for visual clarity; however,
there were no significant differences among data from
different replicates or repeats of individual experiments
(differences were less than a log10 unit in all cases).
Results
The results presented here report the effects of a two-
hour exposure to H2O2, lactic acid, or acetic acid, with
or without the addition of VF. Data collected at shorter
exposures differed only in the proportion of each bac-
teria inactivated, not in the relative efficacy of the anti-
microbial agents, or in the effect of VF on bacterial
inactivation.
Microbicidal activity of hydrogen peroxide
A two-hour anaerobic exposure to 100 mM H2O2 with
50 mU/mL MPO at pH 7 reduced the viability of all
four vaginal lactobacilli species and all seventeen BV-
associated bacterial species to undetectable levels (a
measured reduction of between 10
6 and 10
9 organisms
per mL, depending on the initial bacterial concentra-
tion). This demonstrates the broad-spectrum activity of
H2O2 (Figure 1). However, this concentration is approxi-
mately 50-fold higher than lactobacilli are capable of
producing even under optimal aerobic, low-antioxidant
conditions, and approximately 5,000-fold higher than
the estimated H2O2 concentration in vivo (VF). The
microbicidal activity of H2O2 was not enhanced by
lower pH; indeed, at pH 4.5 H2O2 with MPO produced
less reduction in viability than at pH 7, presumably due
to reduced activity of MPO at the lower pH (data not
shown). The addition of just 1% bacterially depleted VF
completely blocked the microbicidal activity of 1 M
H2O2 with 50 mU/mL myeloperoxidase at pH 7; no sig-
nificant inactivation was detected in any of the eleven
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Figure 1 Microbicidal activity of hydrogen peroxide (H2O2) with 50 mU/mL human myeloperoxidase (MPO) at pH 7, against four
species of vaginal lactobacilli (solid lines) and seventeen species of bacteria associated with bacterial vaginosis (BV) (broken lines).
The vertical dashed line indicates the concentration of H2O2 measured in vaginal fluid (VF) from women with a lactobacilli-dominated
microbiota (~ 23 μM).
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ing that we tested the effect of 1M H2O2 to determine
the potency of VF for blocking the microbicidal activity
of H2O2, but this concentration is higher than is physio-
logically plausible.
Microbicidal activity of acidity, lactic acid, and acetic acid
Acidity alone (pH 4.5 compared to pH 7) reduced the
viability of all seventeen BV-associated bacteria (a reduc-
tion of between two-fold and 10
4-fold, depending on
bacterial species) after two hours exposure, but had no
effect on any of the four lactobacilli species tested ("0,
pH 7”,a n d“0, pH 4.5” data points in Figure 3). Simi-
larly, acetic acid caused essentially no additional inacti-
vation compared to pH 4.5 alone except at 0.8 M (5%
w/v), where it caused only partial additional inactivation
(Figure 4).
In striking contrast, the addition of lactic acid greatly
increased the microbicidal potency at pH 4.5: 0.5% w/v
(56 mM) lactic acid, a concentration and acidity at the
lower end of the range observed in a healthy vaginal
environment [29], dramatically reduced the viability of
all BV-associated species, with all but one (M. mulieris)
reduced to undetectable levels (a measured reduction of
10
6-fold to 10
8-fold depending on the initial bacterial
concentration). Not surprisingly given that they produce
lactic acid, all four lactobacilli species tested were
unaffected by lactic acid at a concentration of 0.5% w/v
(56 mM); indeed, the lactobacilli were unaffected by
10% w/v (1110 mM) lactic acid, an order of magnitude
more lactic acid than we measured in VF from women
with a lactobacilli-dominated vaginal microbiota [[29],
and manuscript in preparation]. Moreover, addition of
1% or 10% v/v bacterially-depleted VF did not change
the microbicidal effect of 56 mM lactic acid at pH 4.5;
all BV-associated bacteria tested were completely inacti-
vated, and lactobacilli were unaffected (Figure 5). The
microbicidal activity of lactic acid required low pH; at
pH 7.0 lactic acid did not inactivate any of the bacteria
tested (data not shown).
Discussion
Here we report that physiologically plausible concentra-
tions of H2O2 had no microbicidal activity, while a
supraphysiologic concentration of exogenous H2Os
(0.34% w/v, 100 mM) just high enough to inactivate BV-
associated bacteria more potently inactivated vaginal lac-
tobacilli. In contrast, physiological concentrations of lac-
tic acid (0.5% w/v, 56 mM) at pH 4.5 completely
inactivated sixteen of the seventeen species of BV-asso-
ciated bacteria tested; pH 4.5 is the highest pH likely to
occur when lactobacilli dominate the vaginal bacterial
community [[25], and manuscript in preparation]. The
differential effect observed was opposite to that expected
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Figure 2 The blocking effect of bacterially-depleted VF on the microbicidal activity of 1 M H2O2 with 50 mU/mL MPO, which is
otherwise sufficient to inactivate completely four species of lactobacilli (solid lines) and seven species of BV-associated bacteria
(broken lines).
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Page 5 of 8if lactobacilli suppress BV-associated bacteria with
H2O2. This also argues against the possibility that H2O2
might be protective at high local concentrations. Addi-
tionally, as we have previously reported, addition of only
1% VF blocks the microbicidal activity of H2O2-
producing strains of lactobacilli even in an optimized,
aerobic, low-antioxidant buffer system [4].
At low pH, small weak acids like acetic acid and lactic
acid become uncharged free acids that are lipid soluble,
membrane permeant, and capable of acidifying the
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with a lactobacilli-dominated vaginal microbiota (93 mM).
100
1000
10000
100000
1000000
0000000
00000000
00000000
B.ureolyticus
L.gasseri
L.jensenii
M.mulieris
L.crispatus
L.iners
G.vaginalis
P.acnes
P.corporis
A.vaginae
M.curtisii
F.nucleatum
P.anaerobius
U.urealyticum
A.tetradius
A.prevotii
Mm i c r o s
103
104
105
106
107
108
109
o
r
m
i
n
g
 
u
n
i
t
s
/
m
L
a
f
t
e
r
 
2
 
h
o
u
r
s
 
e
x
p
o
s
u
r
e
0
1
10
100
0 0 0 1 10 100 1000
M.micros
M.elsdenii
P.levii
P.bivia
M.hominis
pH 7                 l        Acetic acid concentration (mM) at pH 4.5        l
100
101
102
0                    0                   1.0                 10                100               1000   
C
o
l
o
n
y
 
f
// /
Figure 4 Microbicidal activity of acetic acid at pH 4.5 against four species of vaginal lactobacilli (solid lines) and seventeen species of
BV-associated bacteria (broken lines).
O’Hanlon et al. BMC Infectious Diseases 2011, 11:200
http://www.biomedcentral.com/1471-2334/11/200
Page 6 of 8cytosol. The pKa for acetic acid is ~ 4.8, thus when vagi-
nal pH is < 4, acetic acid exists primarily as the
uncharged free acid. In contrast, the pKa for lactic acid
is ~ 3.8 and thus at vaginal pH much of it is the far less
membrane permeant lactate anion. Acetic acid is both
smaller and more lipid soluble than lactic acid and
hence acetic acid is expected to acidify the cytosol more
rapidly than lactic acid and be more rapidly bactericidal
than lactic acid. Despite this expectation, we found that
acetic acid had no detectable effects until its concentra-
tion was increased to 5% (household vinegar). Therefore,
the marked inhibition of BV-associated bacteria by lactic
acid clearly indicates that the antimicrobial action of
lactic acid is not based simply on cytosolic acidification.
Instead, as suggested by other studies, lactic acid
appears to have specific effects, for example, disturbing
the cell membranes of Gram-negative bacteria [22].
Menstrual fluid neutralizes the vagina, and we found
that at pH 7 lactic acid had no microbicidal activity
against BV-associated bacteria. This result is consistent
with the clinical observation of BV recurrence after
menses [30,31].
Our observations carry the caveat of all in vitro obser-
vations, namely that the activities of H2O2, lactic acid,
and acetic acid in vitro may not be the same as in vivo.
Additionally, inactivation of lactobacilli during a
transient anaerobic exposure to exogenous H2O2 may
not reveal tolerance mechanisms that might occur in
aerobic conditions when lactobacilli can produce
H2O2. However, lactobacilli inactivate themselves by
endogenous H2O2 production [32,33], indicating that
they do not possess adequate mechanisms to overcome
H2O2 toxicity. Lactobacilli and BV-associated bacteria
were used at relatively high concentrations for these
experiments; however, the concentrations used here
reflect those found in vivo. Finally, we investigated sin-
gle species in vitro, not combinations, and there may
be synergistic effects of combinations of BV-associated
bacteria that might significantly alter the results in
vivo.
Conclusions
We found that addition of hydrogen peroxide was not
microbicidal at physiologically plausible concentrations.
When supplied at microbicidal concentrations, H2O2
inactivated vaginal lactobacilli somewhat more potently
than BV-associated bacteria. Conversely, addition of lac-
tic acid at physiological concentrations was microbicidal
against BV-associated bacteria, but had no effect on
vaginal lactobacilli. Additionally, the presence of VF
blocked the microbicidal activity of H2O2 but not of lac-
tic acid. We conclude that H2O2 production by lactoba-
cilli is an implausible mechanism for suppressing BV-
associated bacteria in vivo, and that lactic acid produc-
tion at rates that acidify the vagina may potently sup-
press BV-associated bacteria.
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Figure 5 The effect of bacterially-depleted VF on the microbicidal activity of 100 mM lactic acid at pH 4.5, which is otherwise
sufficient to inactivate completely seven species of BV-associated bacteria (broken lines), but not four species of lactobacilli (solid
lines).
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